Home
About
Pages
Home
About
Agenda
Speakers
Tickets
Blog
Contact
Link
Agenda
Speakers
Contact
Your Cart
US$ 0.00 USD
:
Remove
No items found.
Product is not available in this quantity.
Hotel Booking
Your Cart
US$ 0.00 USD
:
Remove
No items found.
Product is not available in this quantity.
Buy Tickets
Cell
Sessions
Cell
Enforcing a safe and efficacious CAR T Therapy - The Clinical Perspective
09:00
-
09:40
Cell
Improving Targeting and Transfection Efficiency of In Vivo CAR-T therapy
09:00
-
09:30
Cell
IL-18-secreting chimeric antigen receptor T cells targeting glypican-3 for the treatment of hepatocellular carcinoma
09:00
-
09:40
Cell
Transforming Donor Blood Cells and iPSCs into “Off-the-shelf” “Broad-Spectrum” Cancer Killers
09:40
-
10:20
Cell
Metabolically armed CAR-T cells for treatment of solid tumors
09:40
-
10:20
Cell
STEM-T technology to empower adoptive T cell therapy in solid tumor setting
10:50
-
11:30
Cell
Harnessing immune cell therapies for improved clinical response in solid tumors
10:50
-
11:30
Cell
Novel CD7-CAR T and CAR-γδT cell therapies exhibited encouraging pre-clinical and clinical efficacy for T cell malignancies
11:30
-
12:10
Cell
CAR T targeting solid tumors: Challenges and opportunities
11:30
-
12:10
Cell
Innovating Cancer Immunotherapy: GCC19CART's Journey from Bench to Bedside
13:10
-
13:50
Cell
Advancing Cell Therapy for Retinal Diseases
13:10 pm
-
13:50 pm
Cell
The Promise of TCR-T cell Therapy for Solid Tumors
13:50
-
14:30
Cell
Optimization of Cell Therapy Development: Public and Private Synergy in Collaboration, Regulation, and Investment in Indonesia
13:50
-
14:30
Cell
Discovery of T Cell Receptors for TCR-based immune therapies
14:30
-
15:10
Cell
Revolutionizing Solid Tumor Therapeutics Through TCR Therapy
15:30
-
16:10
Cell
The development and optimization of in-house CAR T generation and manufacturing procedure
15:30
-
16:10
Cell
Enhancing CAR-T therapy using distinctions between CAR and TCR signaling
16:10
-
16:50
Cell
Challenges in manufacturing natural killer (NK) cells for allogeneic immune cell therapies targeting solid tumors
16:10
-
16:50
Cell
CAR-M from Human Pluripotent Stem Cells Targeting Solid Tumors
16:50
-
17:30
Cell
“Armed” oncolytic herpes simplex virus enables CD19/BCMA CAR-T for solid tumor treatment as a combination therapy
16:50
-
17:30
Are you ready?
Get Early Access to
BioCon Asia-ACGT Conference
!
Buy Tickets
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
